Filters

IL1RAPL2/IL-1R9 Antibody, Cy7 Conjugated

IL1RAPL2/IL-1R9 Antibody, Cy7 Conjugated size: 0.1ml 350

Supplier BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price 350
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name Cy7 Conjugated, IL1RAPL2/IL-1R9 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenIL1RAPL2/IL-1R9
SpecificityThis is a highly specific antibody against IL1RAPL2/IL-1R9
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Subcellular locationExtracellular
SourceKLH conjugated synthetic peptide derived from human IL1RAPL2/IL-1R9
Tested applications IF(IHC-P), FCM
Recommended dilutions IF(IHC-P)(1:50-200), FCM(1:20-100)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background IL-1R9 and IL-1R8 do not activate NF-kB, IL-1R9 is highly homologous to IL-1R8 and the IL-1 accessory protein receptor chains, It is a single pass transmembrane protein with a highly conserved cytoplasmic region that is slightly longer than that of other family members, The genes encoding IL-1R9 and IL-1R8 are both found on the X-chromosome in the region associated with X-linked non-syndromic mental retardation, Unlike other family members, IL-1R9 is a member of the interleukin-1/Toll-like receptor family expressed in fetal brain
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
Synonyms IL-1R9 TIGIRR-1 IL1RAPL-2 IL1R9
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetIL1RAPL2/IL-1R9 Conjugated
Short name Conjugated, IL1RAPL2/IL-1R9 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, interleukin 1 receptor accessory protein-like 2/Interleukin-1R9 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target IL1RAPL2 and IDBG-633230 and ENSBTAG00000044025 and 523444, IL1RAPL2 and IDBG-80984 and ENSG00000189108 and 26280, Il1rapl2 and IDBG-173736 and ENSMUSG00000059203 and 60367, Plasma membranes, Type II, Type II, Type II, blocking receptor activity, blocking receptor activity and also this GO :0005515: protein binding, blocking receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0007165 and signal transduction and biological process this GO :0007417 and central nervous system development and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0019221 and cytokine-mediated signaling pathway and biological process, interleukin-1, this GO :0004908 and interleukin-1 receptor activity and molecular function this GO :0004910 and interleukin-1, this GO :0004908: interleukin-1 receptor activity, this GO :0004908: interleukin-1 receptor activity and also this GO :0004910: interleukin-1, this GO :0004910: interleukin-1, this GO :0005515: protein binding, interleukin 1 receptor accessory protein-like 2
Identity 5997
Gene IL1RAPL2
Long gene name interleukin 1 receptor accessory protein like 2
Locus Xq22, 3
Discovery year 1999-11-19
GenBank acession AF181285
Entrez gene record 26280
Pubmed identfication 10757639
RefSeq identity NM_017416
Classification Immunoglobulin like domain containing Interleukin receptors TIR domain containing
Havana BLAST/BLAT OTTHUMG00000022141
Locus Specific Databases Mental Retardation database

Similar products

Subscribe to our Newsletter